Links to publications that use this kit:
Inan et al. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats.Pharmacol Biochem Behav. 2006 Sep;85(1):39-43.
Lee et al. Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioids levels in nicotine dependence after naltrexone treatment.Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):639-47.
Inan et al. Reduced kappa-opioid activity in a rat model of cholestasis.Eur J Pharmacol. 2005 Aug 22;518(2-3):182-6.
